2011
DOI: 10.1016/j.ijpharm.2010.10.047
|View full text |Cite
|
Sign up to set email alerts
|

Controlling barrier penetration via exothermic iron oxidation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 19 publications
0
11
0
Order By: Relevance
“…The intensity of heat generated depends on the initiator. Generally, there are two initiators such as oxygen and water employed in commercial transdermal patches [57,60]. An additional air permeable pouch is packed with the patches wherever oxygen is used as initiator.…”
Section: Chemical Heating Based Thermal Ablationmentioning
confidence: 99%
“…The intensity of heat generated depends on the initiator. Generally, there are two initiators such as oxygen and water employed in commercial transdermal patches [57,60]. An additional air permeable pouch is packed with the patches wherever oxygen is used as initiator.…”
Section: Chemical Heating Based Thermal Ablationmentioning
confidence: 99%
“…Although control of the exothermic reaction at the skin surface is complex, the iron oxidation reaction could offer an elegant means of generating heat [91]. The FDA has approved the lidocaine/tetracaine transdermal patch (Synera®; Nuvo Research Inc., Canada) that employs CHADD™ heating POD based on an iron oxidation reaction as a source of heat energy (Fig.…”
Section: Transdermal Drug Delivery Using Chemical Heatingmentioning
confidence: 99%
“…Upon mixing of oxygen with the reaction mixture, heat is generated, which can maintain the skin surface temperature at approximately 42°C for up to 4 h, or even longer. However, a reaction being initiated by oxygen is deemed slower and inefficient, compared with the more recently reported reaction that utilises water as the reaction initiator [91]. Wood et al compared both oxygen and water types of initiated reactions and demonstrated their effects on the release of lidocaine at saturated and sub-saturated levels from a carboxymethyl cellulose (CMC) hydrophilic matrix Fig.…”
Section: Transdermal Drug Delivery Using Chemical Heatingmentioning
confidence: 99%
See 1 more Smart Citation
“…Some patches have incorporated a layer of reagents in the patch that could produce heat when activated. These heat-enhanced patches have been successfully applied for drugs, such as corticosteroids (20) and local anesthetics (21). Nuvo Research Inc. (22) has developed a controlled heat-assisted drug delivery (CHADD™) technology that is already approved for use in several products such as Synera® for the heat assisted topical delivery of lidocaine and tetracaine.…”
Section: Introductionmentioning
confidence: 99%